Share
Stelis Biopharma commences construction
01 Jan 2015
1 Min Read
Editorial Team
STELIS Biopharma commenced the construction of its customised, multi-product, biopharmaceutical manufacturing facility at Nusajaya in Johor. STELIS Biopharma and Bio-XCell had previously announced the signing of a build and lease agreement with Bio-XCell for the construction of the building and part of the equipment of the company´s 140,000 sq ft facility, for a total investment amount of $60 mn. The facility will incorporate ´next-gen´ single-use bio-processing technology with both mammalian and microbial manufacturing suites.
Contact: Stelis Biopharma.
Tel: 080-2780 5529. Fax: 080-6784 0800.
Contact: Stelis Biopharma.
Tel: 080-2780 5529. Fax: 080-6784 0800.
STELIS Biopharma commenced the construction of its customised, multi-product, biopharmaceutical manufacturing facility at Nusajaya in Johor. STELIS Biopharma and Bio-XCell had previously announced the signing of a build and lease agreement with Bio-XCell for the construction of the building and part of the equipment of the company´s 140,000 sq ft facility, for a total investment amount of $60 mn. The facility will incorporate ´next-gen´ single-use bio-processing technology with both mammalian and microbial manufacturing suites. Contact: Stelis Biopharma. Tel: 080-2780 5529. Fax: 080-6784 0800.
Related Stories
Gold Stories
Opinion Poll
Question : What are you most interested in Construction Technology?
Live Results :
Project Management Software
BIM
Data Analytics and Dashboard Tools
Drones
Land Management Tools
AI & 3D Printing
Latest updates
19 Apr 2024